bupranolol has been researched along with Coronary Artery Vasospasm in 1 studies
Bupranolol: An adrenergic-beta-2 antagonist that has been used for cardiac arrhythmia, angina pectoris, hypertension, glaucoma, and as an antithrombotic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bobrov, VA | 1 |
| Simorot, VN | 1 |
1 trial available for bupranolol and Coronary Artery Vasospasm
| Article | Year |
|---|---|
[The clinical evaluation of the efficacy of Isoket in patients with vasospastic stenocardia].
Topics: Adult; Angina Pectoris; Bupranolol; Chi-Square Distribution; Coronary Vasospasm; Delayed-Action Prep | 1992 |